Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 40 years of experience and 750 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiac safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings. For more information please visit www.celerion.com.
Clinical Pharmacology, Clinical Trial Design, Data Management, Digitized QTc Analysis, Electronic Submissions Preparation, Mass Spectrometry, Pharmacokinetic/Pharmacodynamic Modeling, Programming (Database/SAS/etc), Protocol Development, Regulatory Affairs/Regulatory Strategy
621 Rose Street
Phone : 4024762811
Fax : 8663587993
Internet : www.celerion.com
Email : firstname.lastname@example.org
Contact Person : Farzana Azam Executive Director, Global Marketing